Therapy News and Research

RSS

New targeted oral therapy results in durable responses across many kinds of cancer

Scientists may have developed the first targeted, oral, tumor-type agnostic therapy - a cancer medicine that works comparably well across many kinds of cancer, regardless of patient age. In clinical trials of adults and children with 17 different types of advanced cancer, larotrectinib treatment resulted in responses in 76% of patients.

5 Jun 2017

Bed partners may unintentionally contradict treatment recommendations for insomnia patients

Preliminary results from a new study show that partners of people who have insomnia may try to be supportive by engaging in a range of behaviors that unintentionally contradict treatment recommendations.

5 Jun 2017

Newborns of mothers with sleep apnea have higher risk of congenital anomalies, resuscitation at birth

A new study is the first to demonstrate a higher risk of congenital anomalies and resuscitation at birth in newborns of mothers who have obstructive sleep apnea.

5 Jun 2017

Standard therapy plus abiraterone lowers relative risk of death in men with advanced prostate cancer

A clinical trial of nearly 2,000 men shows that adding abiraterone acetate (Zytiga) to a standard initial treatment regimen for high-risk, advanced prostate cancer lowers the relative risk of death by 37%.

5 Jun 2017

Study provides reassurance to breast cancer survivors who contemplate pregnancy

Findings from a retrospective study of 1,200 women provide reassurance to breast cancer survivors who are contemplating pregnancy.

5 Jun 2017

$Study finds higher risk of fractures among older, long-term bisphosphonate users$

Study finds higher risk of fractures among older, long-term bisphosphonate users

Osteoporosis is a disease that causes thinning of the bones, loss of bone density, and increasingly fragile bones. This puts people at higher risk for bone fractures. Risk for the disease increases as we age. In fact, 50% of women over the age of 50 will experience a bone facture due to osteoporosis.

2 Jun 2017

Combination therapy shows potential for effective treatment of RAS-mutant cancers

A study at The University of Texas MD Anderson Cancer Center has shown promise for effective treatment of therapy-resistant cancers caused by a mutation of the RAS gene found in many cancers.

2 Jun 2017

Patients nearing end of life may not feel abandoned after discontinuation of cholesterol medications

New research suggests patients nearing the end of their lives because of a "life-limiting illness" such as cancer or heart disease may not feel medically abandoned if their doctor wants to take them off the statins that control their cholesterol.

2 Jun 2017

Expedited partner therapy for STIs provides health and cost benefits

In some states, patients who test positive for chlamydia or gonorrhea leave the clinic with not only a prescription for themselves, but also one for their sexual partner -- who was not seen by a doctor.

2 Jun 2017

Genetic sequencing could help direct treatment for 72% of advanced cancer patients

A new analysis finds that nearly three-quarters of 500 patients with advanced cancer could be referred to a potential targeted treatment based on the results of a comprehensive analysis of their tumor's genetic landscape.

2 Jun 2017

Long-term chronic bone loss occurs even after one time malaria infection

Malaria caused by Plasmodium parasites is a life-threatening infectious disease that kills at least half a million people annually while causing over 200 million new infections.

2 Jun 2017

Gene therapy could give protection from severe allergies

A single treatment giving life-long protection from severe allergies such as asthma could be made possible by immunology research at The University of Queensland.

2 Jun 2017

Scientists receive $2.3 million NIH grant to uncover how omega-3 fatty acid stops lupus trigger

Michigan State University scientists have received a $2.3 million, five-year National Institutes of Health grant to help uncover why an omega-3 fatty acid, known as DHA, is so effective in stopping a known trigger of lupus.

2 Jun 2017

Compression tights don't help runners go farther or faster, study finds

Despite the fact that distance runners swear by them, a new study from The Ohio State University Wexner Medical Center finds compression tights don't help runners go farther or faster.

2 Jun 2017

Researchers find new way to block type 1 diabetes

Researchers at The Jackson Laboratory, Cyteir Therapeutics and collaborating institutions have found a way to protect beta cells from destruction -- achieving a longtime, elusive goal that could lead to therapies preventing type 1 diabetes (T1D).

1 Jun 2017

TMS therapy offers hope for senior adults with depression

Late-life depression (LLD) is a frequent complication of the aging process, occurring in up to 5% of senior adults and in a higher proportion of subjects with coexistent medical illnesses.

1 Jun 2017

Scientists identify new gene that prompts muscle stem cells to fuse together

A detour on the road to regenerative medicine for people with muscular disorders is figuring out how to coax muscle stem cells to fuse together and form functioning skeletal muscle tissues.

1 Jun 2017

HPV infection more likely to develop into cervical pre-cancer in women with HIV

A study of Senegalese women showed that human papillomavirus (HPV) infection was more likely to develop into cervical pre-cancer in women living with human immunodeficiency virus.

1 Jun 2017

Innovation in natural health supplementation

The market has changed quite a lot. When I first investigated the industry, and launched BetterYou the natural heath industry was the domain of the educated few. People did a lot of research before they walked into a health store; they knew the questions they wanted to ask and expected quite a good deal of information in return.

From BetterYou Ltd 1 Jun 2017

Experimental drug increases progression-free survival in pancreatic cancer patients, clinical trial shows

By adding an experimental drug to a standard chemotherapy regimen, a subset of patients with metastatic pancreatic cancer had a significantly longer period before the cancer progressed as compared with those who received the standard treatment, according to a Phase 2 clinical trial led by an investigator at Fred Hutchinson Cancer Research Center.

1 Jun 2017

Therapy News and Research

New targeted oral therapy results in durable responses across many kinds of cancer

Bed partners may unintentionally contradict treatment recommendations for insomnia patients

Newborns of mothers with sleep apnea have higher risk of congenital anomalies, resuscitation at birth

Standard therapy plus abiraterone lowers relative risk of death in men with advanced prostate cancer

Study provides reassurance to breast cancer survivors who contemplate pregnancy

Study finds higher risk of fractures among older, long-term bisphosphonate users

Combination therapy shows potential for effective treatment of RAS-mutant cancers

Patients nearing end of life may not feel abandoned after discontinuation of cholesterol medications

Expedited partner therapy for STIs provides health and cost benefits

Genetic sequencing could help direct treatment for 72% of advanced cancer patients

Long-term chronic bone loss occurs even after one time malaria infection

Gene therapy could give protection from severe allergies

Scientists receive $2.3 million NIH grant to uncover how omega-3 fatty acid stops lupus trigger

Compression tights don't help runners go farther or faster, study finds

Researchers find new way to block type 1 diabetes

TMS therapy offers hope for senior adults with depression

Scientists identify new gene that prompts muscle stem cells to fuse together

HPV infection more likely to develop into cervical pre-cancer in women with HIV

Innovation in natural health supplementation

Experimental drug increases progression-free survival in pancreatic cancer patients, clinical trial shows

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News